Antiviral Candidates for Treating Hepatitis E Virus Infection-Reference-Cited by-同舟云学术

Antiviral Candidates for Treating Hepatitis E Virus Infection

Published:2019-06 Issue:6 Volume:63 Page:
ISSN:0066-4804
Container-title:Antimicrobial Agents and Chemotherapy
language:en
Short-container-title:Antimicrob Agents Chemother

Author:

Netzler Natalie E.¹^ORCID,Enosi Tuipulotu Daniel¹^ORCID,Vasudevan Subhash G.²^ORCID,Mackenzie Jason M.³^ORCID,White Peter A.¹^ORCID

Affiliation:

1. School of Biotechnology and Biomolecular Sciences, Faculty of Science, University of New South Wales, Sydney, NSW, Australia

2. Emerging Infectious Diseases Programme, Duke-NUS Medical School, Singapore

3. Department of Microbiology and Immunology, The Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, VIC, Australia

Abstract

Globally, hepatitis E virus (HEV) causes significant morbidity and mortality each year. Despite this burden, there are no specific antivirals available to treat HEV patients, and the only licensed vaccine is not available outside China.

Funder

Australian National Health and Medical Research Council

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

Link

https://journals.asm.org/doi/pdf/10.1128/AAC.00003-19

Reference94 articles.

1. The global burden of hepatitis E virus genotypes 1 and 2 in 2005

2. World Health Organization. 19 September 2018. Hepatitis E fact sheet. http://www.who.int/news-room/fact-sheets/detail/hepatitis-e. World Health Organization, Geneva, Switzerland. Accessed 21 October 2018.

3. Hepatitis E vaccine debuts

4. Antiviral strategies for hepatitis E virus

5. Chronic Hepatitis E Virus Infection: Successful Virologic Response to Pegylated Interferon-α Therapy

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Performance of sofosbuvir and NITD008 in extrahepatic neuronal cells against HEV;Antiviral Research;2024-07

2. Realm of hepatitis E: Challenges and opportunities;World Journal of Experimental Medicine;2024-06-20

3. Drug repurposing screen identifies vidofludimus calcium and pyrazofurin as novel chemical entities for the development of hepatitis E interventions;Virologica Sinica;2023-11

4. Inhibition of HEV Replication by FDA-Approved RdRp Inhibitors;ACS Omega;2023-10-27

5. Antiviral activity of zinc against hepatitis viruses: current status and future prospects;Frontiers in Microbiology;2023-10-16